Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07446738 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

Study acronym: PREDICT
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 2 of 2 changed
See other at-risk trials from AstraZeneca

Record History

  1. Primary endpoint(s) modified Enrollment closed, study ongoing · Trial sites expanded: 18 → 21 locations · Final enrollment: 146 participants (planned 200) · 4 more Show 7 more changesShow less
    • Enrollment closed, study ongoing
    • Trial sites expanded: 18 → 21 locations
    • Final enrollment: 146 participants (planned 200)
    • Interventions modified
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: 30 to 46
    • Study description expanded, about 88 words
  2. Re-verified, no change to tracked fieldsv6
  3. Study sites: 16 to 18 Start date: Mar 20, 2026 to Mar 19, 2026v5 Show 1 more changeShow less
    • Start date: Mar 20, 2026 to Mar 19, 2026
  4. Primary and study completion pushed from Aug 30, 2027 to Oct 21, 2027 Site details revised at 3 of 16 sitesv4 Show 1 more changeShow less
    • Site details revised at 3 of 16 sites
  5. Trial sites expanded: 10 → 16 locationsv3
  6. Recruitment opened Trial sites reduced: 19 → 10 locations · Primary and study completion dates: Aug 21, 2027 to Aug 30, 2027 · Start date changed from estimate of Mar 31, 2026 to Mar 20, 2026v2 Show 3 more changesShow less
    • Trial sites reduced: 19 → 10 locations
    • Primary and study completion dates: Aug 21, 2027 to Aug 30, 2027
    • Start date changed from estimate of Mar 31, 2026 to Mar 20, 2026
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AstraZeneca
727 trials monitored
See 61 trials at risk
This is a prospective, multicenter real-world observational study designed to describe post-operative outcomes, quality of life, disease control, recurrence-related characteristics, economic burden and post-operative treatment patterns in Chinese patients with CRSwNP undergoing endoscopic sinus surgery (ESS).
Trial Details
NCT Number NCT07446738
Lead Sponsor AstraZeneca
Conditions Chronic Rhinosinusitis With Nasal Polyps
Enrollment 146 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov